Key result
Current risk assessment models for venous thrombosis in hospitalized medical patients demonstrate limited performance, contributing to differing guidelines on thromboprophylaxis regimens.
Why the study?
Guidelines differ on thromboprophylaxis regimens, possibly due to the limited performance of current risk assessment models used to predict venous thrombosis in medical patients.
Do risk assessment models accurately predict venous thrombosis in hospitalized medical patients?
Do risk assessment models accurately predict venous thrombosis in hospitalized medical patients?
Validation of risk assessment models for venous thrombosis in hospitalized medical patients is needed to guide pharmacological thromboprophylaxis.
Answers are grounded in this paper and cite their sources.
Limited performance warrants cautious use for thromboprophylaxis decisions; leaves open need for validated, accurate risk models.
Background: Risk assessment models (RAMs) have been developed to predict which medical patients are at high risk for venous thrombosis (VT) and hence, should receive pharmacological thromboprophylaxis. Possibly due to the limited performance of the current models, guidelines differ on thromboprophylaxis regimens.
No takes yet. Share an insight, caveat, or question.
Cobben et al. (2019) studied this question. Current risk assessment models for venous thrombosis in hospitalized medical patients demonstrate limited performance, contributing to differing guidelines on thromboprophylaxis regimens.
Synapse has enriched 10 related papers. Consider them for comparative context: